A Blinded Comparison Trial of Two Topical Creams to Reduce Thigh Girth and to Smooth Thigh Skin in Women
NCT01920841 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2015-12-18
Summary
The purpose of this study is to evaluate efficacy of two lipolytic creams differing in their bases and demonstrate that their herbal ingredients can reduce the size of the thigh and smooth the appearance of the thigh skin. It is hypothesized that creams with two different cream bases containing herbal products that stimulate the lipolytic process through stimulation of the beta-adrenergic receptor, with one cream base applied to each thigh daily 5 days a week for 4 weeks will reduce thigh girth and smooth the thigh skin compared to baseline.
Conditions
Interventions
- OTHER
-
Cream A applied to left thigh and Cream B to right thigh
Half the participants will receive Cream A applied to the left thigh, and Cream B applied to the right thigh
- OTHER
-
Cream B applied to left thigh and Cream A to right thigh
Half the participants will receive Cream B applied to the left thigh and Cream A applied to the right thigh
Sponsors & Collaborators
-
Nerium Biotechnology Inc
collaborator UNKNOWN -
Pennington Biomedical Research Center
lead OTHER
Principal Investigators
-
Frank L Greenway, M.D. · Pennington Biomedical Research Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 52 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2014-03-31
- Completion
- 2014-03-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy of Pharmacological Stimulation of BAT and WAT in Lean and Obese Young Adults
NCT02354807 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison of the Effect of Intense-Exercise/Moderate-Calorie, Topiramate-Phentermine and Cognitive Behavioral Therapy on Obesity
NCT01970566 ·Status: WITHDRAWN ·Phase: NA
-
Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat
NCT02397499 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
NCT07140939 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety and Efficacy of IQP- AK-102 in Reducing Body Weight
NCT01905956 ·Status: COMPLETED ·Phase: PHASE3
-
Weight Loss, Blood Sugar and Blood Lipid Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips
NCT05574049 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Efficacy and Safety of IQP-VV-102 in Weight Management
NCT01681069 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of NT-0796 in Obese Participants at Risk of Cardiovascular Disease
NCT06129409 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Deoxycholic Acid Injection for Reduction of Upper Inner Thigh Fat
NCT04054011 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Patients Being Treated With Anti-obesity Medication
NCT06790160 ·Status: RECRUITING
-
Safety and Efficacy Study of 10XB-101 in Adults With Bilateral Flank Adiposity
NCT05760248 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss
NCT03811093 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of ZT006 in Overweight and Obese Participants
NCT07230132 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects
NCT02568319 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy, Safety and Tolerability of CBL-514 Injection for Reducing Abdominal Subcutaneous Fat
NCT05736107 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety and Effects of Garetosmab in Healthy Obese Men and Post-Menopausal Women
NCT06970405 ·Status: WITHDRAWN ·Phase: PHASE1
-
Efficacy and Safety of the BeShape One Device for Non-invasive Waist Circumference Reduction
NCT05896696 ·Status: COMPLETED ·Phase: NA
-
Benefit and Tolerability of IQP-LU-104 in Weight Loss
NCT03888911 ·Status: COMPLETED ·Phase: NA
-
Body Fat Reducing Effect and Safety of Enzymatically Modified Isoquercitrin in Overweight and Obese Subjects
NCT02818699 ·Status: COMPLETED ·Phase: NA
-
Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults
NCT02501356 ·Status: COMPLETED ·Phase: NA
-
Evaluate the Efficacy and Safety of NT-0796 in Participants With Obesity With or Without Type 2 Diabetes Mellitus
NCT07055516 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Zenoctil in Reducing Body Weight
NCT01423617 ·Status: COMPLETED ·Phase: PHASE3
-
Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity
NCT05834062 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Tolerance and Pharmacokinetic Study of Trodusquemine in Healthy Volunteers
NCT00509132 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Sibutramine in Overweight Adolescents to Assess Weight Loss and Safety.
NCT00261911 ·Status: COMPLETED ·Phase: PHASE3